AOD-9604 vs Lipo-C Injection
A side-by-side research comparison of AOD-9604 and Lipo-C Injection across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | AOD-9604 | Lipo-C Injection |
|---|---|---|
| Full name | Advanced Obesity Drug Fragment 176-191 (Modified) | Lipotropic MIC + B12 Injection |
| Category | Weight Management | Weight Management |
| Status | Research compound | Compounded medication |
| Mechanism | Mimics the lipolytic domain of growth hormone (hGH 176-191), stimulating fat oxidation and inhibiting de novo lipogenesis through pathways independent of IGF-1 and growth signaling. | Methionine provides sulfur for detoxification, inositol supports fat transport from liver, choline emulsifies cholesterol and fat, B12 boosts cellular energy metabolism and red blood cell production. |
| Molecular weight | 1815.08 Da | Combination compound |
| Half-life | ~2-3 hours | Variable by component |
| Bioavailability | ~90% subcutaneous | ~100% IM injection |
| Typical dose | 300 mcg | 1 mL |
| Frequency | Daily (morning, fasted) | 1-2x per week |
| Route | Subcutaneous injection | Intramuscular or subcutaneous injection |
AOD-9604 reported benefits
- Fat loss without muscle wasting
- No effect on blood sugar
- Cartilage repair properties
- No HGH-related side effects
Lipo-C Injection reported benefits
- Enhanced fat metabolism
- Liver support
- Increased energy
- B12 optimization
- Complements weight loss protocols
Related comparisons
Research and educational reference only. Not medical advice.